--- title: Buy Budesonide Formoterol Rotacaps 100/6mcg | 200/6mcg description: Budesonide Formoterol Rotacaps 100/6mcg, 200/6mcg, or 400/6mcg control asthma and COPD symptoms. Source from our trusted pharmacy for quality capsules. type: product language: en url: https://liabilis.com/order-budesonide-formoterol-rotacaps-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 35.99 price_max: 134.99 currency: USD offers: - name: 100/6mcg x 30 caps price: 35.99 - name: 100/6mcg x 60 caps price: 44.99 - name: 100/6mcg x 90 caps price: 44.99 - name: 200/6mcg x 30 caps price: 35.99 - name: 200/6mcg x 90 caps price: 89.99 - name: 200/6mcg x 60 caps price: 95.99 - name: 400/6mcg x 30 caps price: 59.99 - name: 400/6mcg x 60 caps price: 104.99 - name: 400/6mcg x 90 caps price: 134.99 --- # Buy Budesonide Formoterol Rotacaps 100/6mcg | 200/6mcg Budesonide Formoterol Rotacaps combine an inhaled corticosteroid and bronchodilator for maintenance treatment of asthma and COPD in adults. They help reduce inflammation and open airways. Available in 100/6mcg, 200/6mcg, or 400/6mcg cap from our online pharmacy. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **100/6mcg** | 30 caps | **$35.99** | $1.20 | In Stock | | **100/6mcg** | 60 caps | **$44.99** | $0.75 | In Stock | | **100/6mcg** | 90 caps | **$44.99** | $0.50 | In Stock | | **200/6mcg** | 30 caps | **$35.99** | $1.20 | In Stock | | **200/6mcg** | 90 caps | **$89.99** | $1.00 | In Stock | | **200/6mcg** | 60 caps | **$95.99** | $1.60 | In Stock | | **400/6mcg** | 30 caps | **$59.99** | $2.00 | In Stock | | **400/6mcg** | 60 caps | **$104.99** | $1.75 | In Stock | | **400/6mcg** | 90 caps | **$134.99** | $1.50 | In Stock | [Buy Now](https://liabilis.com/order-budesonide-formoterol-rotacaps-online-en.html) ## Introduction Budesonide formoterol rotacaps is an inhaled medication that combines an inhaled corticosteroid (budesonide) with a long-acting β₂-agonist (formoterol). It is supplied as a dry-powder inhaler capsule (cap) in three dose strengths-100 µg/6 µg, 200 µg/6 µg, and 400 µg/6 µg per inhalation. The product belongs to the therapeutic class of combination inhaled corticosteroid/long-acting β₂-agonist (ICS/LABA) agents. Its primary indication is the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Some clinicians also employ it for preventing exercise-induced bronchoconstriction, although that use is not formally approved. ## Quick Reference Facts **Active Ingredient** : Budesonide formoterol rotacaps **Form** : cap 100/6 mcg | 200/6 mcg | 400/6 mcg **Primary and Off-Label Uses** : • Maintenance therapy for asthma : • Maintenance therapy for COPD : • Prevention of exercise-induced bronchoconstriction (off-label) ## What is Budesonide formoterol rotacaps? Budesonide formoterol rotacaps is a generic inhalation product that delivers a fixed combination of budesonide (an anti-inflammatory corticosteroid) and formoterol (a rapid-onset, long-duration bronchodilator). It is classified as an ICS/LABA combination, a mainstay of modern maintenance therapy for obstructive airway disease. The generic version mirrors the pharmacological profile of branded products such as Symbicort and Foster, offering the same active ingredients, dosage options, and device design. Because it is a generic, it must demonstrate bioequivalence to the reference brand under regulatory review, ensuring comparable efficacy and safety. The formulation is contained in a rotacaps capsule that is pierced by a breath-activated inhaler, releasing a fine powder that the patient inhales deeply. ## How Budesonide formoterol rotacaps Works The two components act synergistically: * **Budesonide** binds glucocorticoid receptors in airway epithelial cells, altering gene transcription to suppress the production of inflammatory mediators (e.g., cytokines, chemokines). This reduces airway edema, mucus hypersecretion, and hyper-responsiveness, thereby limiting the frequency and severity of asthma or COPD exacerbations. * **Formoterol** stimulates β₂-adrenergic receptors on airway smooth muscle, increasing intracellular cyclic AMP. The result is rapid relaxation of bronchial smooth muscle (onset within minutes) and sustained bronchodilation for up to 12 hours. Because formoterol has a fast onset comparable to short-acting β₂-agonists, patients receive both maintenance control and quick symptom relief from a single inhaler. The inhaled route delivers the drug directly to the lungs, maximizing local effect while minimizing systemic exposure. Budesonide has high first-pass metabolism (> 80 % hepatic), further limiting systemic corticosteroid effects. Formoterol is metabolized primarily by CYP3A4; drug interactions are therefore limited but clinically relevant with strong CYP3A4 inhibitors. ## Conditions Treated with Budesonide formoterol rotacaps - **Asthma (maintenance therapy)** The combination reduces the frequency of daytime symptoms, nocturnal awakenings, and the need for rescue inhalers. Budesonide controls underlying inflammation while formoterol provides lasting bronchodilation, allowing patients to achieve better control with fewer exacerbations. - **Chronic Obstructive Pulmonary Disease (COPD) - stable disease** In COPD, chronic inflammation and fixed airway obstruction benefit from the anti-inflammatory action of budesonide, while formoterol improves exercise tolerance and reduces dyspnea. Clinical guidelines recommend an ICS/LABA for patients with frequent exacerbations or a high symptom burden. - **Prevention of Exercise-Induced Bronchoconstriction (off-label)** Some clinicians prescribe budesonide/formoterol before vigorous activity to blunt the acute narrowing of airways that occurs in susceptible individuals. The rapid onset of formoterol makes it suitable for this purpose, although formal approval for this indication varies by region. ## Is Budesonide formoterol rotacaps the Right Medication for You? **Suitable patients** - Adults (≥ 18 years) with persistent asthma not adequately controlled by low-dose inhaled corticosteroids alone. - Adults with moderate-to-severe COPD who experience frequent exacerbations or persistent symptoms despite bronchodilator monotherapy. - Individuals who prefer a single inhaler for both maintenance and quick relief, reducing device burden. **Clinical scenarios favoring its use** - Patients with a history of nighttime asthma symptoms. - COPD patients with a history of ≥ 2 exacerbations per year. - Those who have demonstrated good inhaler technique with breath-actuated devices. **When it may NOT be appropriate** - Patients with a known hypersensitivity to budesonide, formoterol, lactose, or any excipients in the capsule. - Individuals with uncontrolled narrow-angle glaucoma or cataracts, where systemic corticosteroid exposure could worsen ocular pressure. - Patients requiring exclusive short-acting bronchodilator rescue therapy (formoterol’s long-acting profile may mask worsening disease if not monitored). A thorough assessment by a healthcare professional remains essential before initiating therapy. ## Buying Budesonide formoterol rotacaps from [our online pharmacy](https://liabilis.com/order-budesonide-formoterol-rotacaps-online-en.html) ### Why Choose Our Service? Accessing inhaled medications can be challenging when insurance coverage is limited or when local pharmacies face stock shortages. [our online pharmacy](https://liabilis.com/order-budesonide-formoterol-rotacaps-online-en.html) provides a convenient, cost-effective way to obtain Budesonide formoterol rotacaps, ensuring you stay on your prescribed regimen without interruption. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every batch is sourced from manufacturers that meet stringent Good Manufacturing Practice (GMP) standards, and our supply chain is audited regularly. ### Pricing & Access Because Budesonide formoterol rotacaps is available as a generic, it is priced substantially lower than branded equivalents such as Symbicort or Foster. Our platform offers near-wholesale rates, making long-term maintenance therapy more affordable for patients on a fixed income. ### Discreet Delivery Your privacy is paramount. Orders are packaged in unmarked, tamper-evident envelopes and dispatched via express courier (typically delivered within 7 days) or standard airmail (approximately 3 weeks). Tracking information is provided for every shipment, and no pharmacy branding appears on the outside of the package. ## Use: Dosing, Missed Dose, Overdose **Standard dosing (adult)** - **100 µg/6 µg**: 1 inhalation twice daily (morning and evening). - **200 µg/6 µg**: 1 inhalation twice daily. - **400 µg/6 µg**: 1 inhalation twice daily; reserved for patients requiring higher anti-inflammatory strength. The inhaler should be primed according to the manufacturer’s instructions before first use. Patients are advised to inhale forcefully and deeply, holding the breath for 5-10 seconds after each dose. **Missed dose** If a scheduled dose is forgotten, take it as soon as remembered **provided at least 4 hours remain before the next scheduled dose**. If the next dose is due within 4 hours, skip the missed dose and resume the regular schedule. Do not double-dose to “make up” for a missed inhalation. **Suspected overdose** Signs of excess corticosteroid exposure may include severe throat irritation, hoarseness, oral candidiasis, or systemic effects such as adrenal suppression. Formoterol overdose may present with tremor, palpitations, or hypokalemia. If overdose is suspected, seek immediate medical attention; treatment is supportive and may involve bronchodilator antagonists for severe β₂-agonist toxicity. **Practical precautions** - Use with a spacer only if instructed; rotacaps are designed for direct inhalation. - Avoid alcohol and sedatives that could impair coordination needed for proper inhaler technique. - Do not drive or operate machinery if you experience dizziness or palpitations after dosing. - Rinse mouth with water and expectorate after each use to reduce risk of oral candidiasis. ## Safety Information ### ⚠️ Who Should Not Take Budesonide formoterol rotacaps - Persons with a documented hypersensitivity to budesonide, formoterol, lactose, or any capsule excipients. - Patients with a history of severe paradoxical bronchospasm triggered by inhaled β₂-agonists. - Individuals receiving systemic corticosteroids for other conditions where additive immunosuppression would be unsafe. ### Common Side Effects - **Oral candidiasis** (thrush) - occurs in up to 10 % of users; mitigated by mouth rinsing. - **Hoarseness or throat irritation** - usually mild and transient. - **Headache** - reported in ≤ 5 % of patients. - **Tremor, palpitations** - related to the β₂-agonist component; often dose-dependent. These effects are generally manageable and tend to lessen with continued use. ### Serious Side Effects (Seek Immediate Medical Help) - **Paradoxical bronchospasm** - sudden worsening of breathing shortly after inhalation. - **Severe allergic reaction** (anaphylaxis): swelling of face or throat, rash, difficulty breathing. - **Cardiac arrhythmias** (e.g., tachycardia, atrial fibrillation) especially in patients with underlying heart disease. - **Adrenal insufficiency** from chronic high-dose corticosteroid exposure (rare). If any of these occur, discontinue the medication and obtain emergency care. ### Drug & Food Interactions - **Strong CYP3A4 inhibitors** (e.g., ketoconazole, ritonavir) may increase systemic exposure to formoterol; monitor for tachycardia or hypokalemia. - **Diuretics** (especially thiazides) can exacerbate hypokalemia when combined with β₂-agonists; electrolyte monitoring is advised. - **Anticholinergic agents** (e.g., ipratropium) can be co-administered without known adverse interaction, offering complementary bronchodilation. - **Food**: No major food interactions, but inhalation technique should not be performed immediately after a large meal that could cause reflux. ## Off-Label and Investigational Uses of Budesonide formoterol rotacaps - **Exercise-Induced Bronchoconstriction (EIB)** - Small clinical studies have shown that a single dose taken 15 minutes before vigorous activity can reduce the drop in forced expiratory volume (FEV₁) associated with EIB. This use remains off-label in many jurisdictions and should only be considered under specialist supervision. - **Post-viral airway hyper-responsiveness** - Early-phase investigations suggest that commencing budesonide/formoterol shortly after an upper respiratory infection may blunt subsequent exacerbations in asthmatic patients. Evidence is preliminary; formal approval is pending. - **Allergic rhinitis adjunct** - Some allergists prescribe low-dose budesonide/formoterol inhalation to target lower airway involvement in severe seasonal allergic rhinitis, though the primary indication remains asthma. All off-label applications lack regulatory endorsement; patients should discuss potential risks and benefits with a qualified healthcare provider before use. ## Storage & Handling - Store caps at **controlled room temperature** (15 °C - 30 °C). - Keep the container tightly closed and protect from moisture and direct sunlight. - Do not freeze; extreme temperatures may degrade the powdered formulation. - Check the expiry date printed on the pack; discard any capsules past this date. - For safe disposal, follow local regulations for pharmaceutical waste or return unused product to a pharmacy-take-back program. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Budesonide formoterol rotacaps?** Yes. Carry the medication in its original packaging with a copy of the prescription or a doctor’s note if required by customs. Keep it in hand luggage to avoid temperature extremes in cargo holds. - **Will the inhaler work at high altitude or on an airplane?** The dry-powder device functions at typical cabin pressures. However, very low humidity may affect powder flow; a short breath-hold technique is advisable. - **Is it safe to use this inhaler while pregnant?** Inhaled corticosteroids are generally preferred over systemic steroids during pregnancy. Budesonide/formoterol is classified as FDA pregnancy category B, indicating no evidence of fetal risk in animal studies, but it should be used only if the clinical benefit justifies potential risks. **Product & Formulation Details** - **What do the rotacaps look like?** The capsules are small, opaque, powder-filled, typically white or off-white, and sealed within a foil blister. Each capsule is numbered for dose verification. - **Are there any lactose or sugar components?** Yes, lactose monohydrate is used as a carrier in the powder. Patients with severe lactose intolerance should discuss alternatives with their prescriber. **Regulatory & Safety Nuances** - **Will Budesonide formoterol rotacaps appear on a sports drug test?** Formoterol is listed on the World Anti-Doping Agency (WADA) prohibited list when used systemically; inhaled use is permitted with a Therapeutic Use Exemption (TUE) in most sports. - **Can elderly patients use this inhaler safely?** Older adults may have reduced inspiratory flow, which can affect powder delivery. Assess inhaler technique regularly and consider a spacer or alternative device if peak inspiratory flow is insufficient. **Scientific & Clinical Curiosity** - **How does the efficacy of Budesonide formoterol rotacaps compare to the branded Symbicort?** Bioequivalence studies required by regulatory agencies have demonstrated that the generic delivers comparable lung deposition, systemic exposure, and clinical outcomes to the reference product. - **When was the budesonide/formoterol combination first approved?** The combination was first authorized by the U.S. FDA in 2006 for asthma maintenance therapy, with subsequent approvals for COPD in 2009. ## Glossary **β₂-Agonist** : A class of drugs that stimulate β₂-adrenergic receptors in airway smooth muscle, causing relaxation and bronchodilation. **Inhaled Corticosteroid (ICS)** : A steroid medication delivered directly to the lungs to reduce airway inflammation with minimal systemic absorption. **Bioequivalence** : Demonstration that two drug products release the same amount of active ingredient into the bloodstream at the same rate and extent. **Paradoxical Bronchospasm** : An unexpected worsening of airway constriction after inhalation of a bronchodilator, requiring immediate medical attention. **Dry-Powder Inhaler (DPI)** : An inhalation device that releases powdered medication upon a forceful inhalation, without the need for propellants. ## Disclaimer The information provided about **Budesonide formoterol rotacaps** is intended for general education only and does not substitute professional medical counsel. Treatment decisions, including any off-label applications, must be made under the guidance of a qualified healthcare professional. Readers are presumed to be competent adults capable of making informed health choices. [our online pharmacy](https://liabilis.com/order-budesonide-formoterol-rotacaps-online-en.html) facilitates access to Budesonide formoterol rotacaps for individuals who may encounter limited availability, insurance constraints, or high costs with branded alternatives. Always discuss with your physician before initiating, altering, or discontinuing any medication.